論文業績
2022年
- Takasu M, Kadoya H, Yamanouchi Y, Nojima Y, Yamamoto T, Itano S, Nakata M, Sasaki T, Kashihara N.:A case of pleuroperitoneal communication during long-term steroid therapy for dermatomyositis. Perit Dial Int. 2022;42(4):434-436.
- Maruyama Y, Araki M, Kidokoro K, Sogawa Y, Yoshinaga K, Mitsui Y, Sadahira T, Wada K, Watanabe M, Watanabe T, Kashihara N, Nasu Y.:Evaluation of Neutrophil Dynamics Change by Protective Effect of Tadalafil After Renal Ischemia/Reperfusion Using In Vivo Real-time Imaging. Transplantation. 2022;106(2):280-288.
- Yano Y, Kanegae H, Node K, Mizuno A, Nishiyama A, Rakugi H, Itoh H, Kitaoka K, Kashihara N, Ikeno F, Tsuji I, Okada K.:The associations of the national health and productivity management program with corporate profits in Japan. Epidemiol Health. 2022;23.
- Okuda Y, Ito S, Kashihara N, Shikata K, Nangaku M, Wada T, Sawanobori T, Taguri M.:The renoprotective effect of esaxerenone independent of blood pressure lowering: a post hoc mediation analysis of the ESAX-DN trial. Hypertens Res. 2022;13.
- James G, Garcia Sanchez JJ, Carrero JJ, Kumar S, Pecoits-Filho R, Heerspink HJL, Nolan S, Lam CSP, Chen H, Kanda E, Kashihara N, Arnold M, Kosiborod MN, Lainscak M, Pollock C, Wheeler DC.:Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility. Kidney Int Rep. 2022;8;7(9):2059-2070.
- Nangaku M, Takama H, Ichikawa T, Mukai K, Kojima M, Suzuki Y, Watada H, Wada T, Ueki K, Narita I, Kashihara N, Kadowaki T, Hase H, Akizawa T.:Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: Design and baseline characteristics of AYAME study. Nephrol Dial Transplant. 2022;24.
- Jongs N, Chertow GM, Greene T, McMurray JJV, Langkilde AM, Correa-Rotter R, Kashihara N, Rossing P, Sjöström CD, Stefánsson BV, Toto RD, Wheeler DC, Heerspink HJL; DAPA-CKD Trial Committees and Investigators.:Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD. J Am Soc Nephrol. 2022;17.
- Kimura T, Yamamoto R, Yoshino M, Sakate R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Nagai K, Yamagata K, Yasuda H, Ichida S, Naruse T, Nishino T, Sobajima H, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Mimura T, Suzuki S, Saka Y, Sofue T, Kitagawa K, Fujita Y, Mizutani M, Kashihara N, Sato H, Narita I, Isaka Y.:Deep learning analysis of clinical course of primary nephrotic syndrome: Japan Nephrotic Syndrome Cohort Study (JNSCS). Clin Exp Nephrol. 2022;12.
- Sato R, Matsuzawa Y, Ogawa H, Kimura K, Tsuboi N, Yokoo T, Okada H, Konishi M, Kirigaya J, Fukui K, Tsukahara K, Shimizu H, Iwabuchi K, Yamada Y, Saka K, Takeuchi I, Kashihara N, Tamura K.:Chronic kidney disease and clinical outcomes in patients with COVID-19 in Japan. Clin Exp Nephrol. 2022;26(10):974-981.
- Sugawara Y, Hirakawa Y, Mise K, Kashiwabara K, Hanai K, Yamaguchi S, Katayama A, Onishi Y, Yoshida Y, Kashihara N, Matsuyama Y, Babazono T, Nangaku M, Wada J.:Analysis of inflammatory cytokines and estimated glomerular filtration rate decline in Japanese patients with diabetic kidney disease: a pilot study. Biomark Med. 2022;16(10):759-770.
- Nakagawa N, Maruyama S, Kashihara N, Narita I, Isaka Y.:New-onset and relapse of nephrotic syndrome following COVID-19 vaccination: a questionnaire survey in Japan. Clin Exp Nephrol. 2022 Sep;26(9):909-916. doi: 10.1007/s10157-022-02231-y. Epub 2022;15.
- Shikata K, Ito S, Kashihara N, Nangaku M, Wada T, Okuda Y, Sawanobori T, Sugimoto K.:Reduction in the magnitude of serum potassium elevation in combination therapy with esaxerenone (CS-3150) and sodium-glucose cotransporter 2 inhibitor in patients with diabetic kidney disease: Subanalysis of two phase Ⅲ studies. J Diabetes Investig. 2022;13(7):1190-1202.
- Handa M, Kato S, Sakurai G, Yabe T, Demura S, Takeshita Y, Kanamori T, Nakano Y, Shinmura K, Yokogawa N, Kashihara N, Yahata T, Takamura T, Tsuchiya H.:The Prevalence of Locomotive Syndrome and its Associated Factors in Patients With Type 2 Diabetes Mellitus. Mod Rheumatol. 2022;2.
- Zheng J, Zhang Y, Rasheed H, Walker V, Sugawara Y, Li J, Leng Y, Elsworth B, Wootton RE, Fang S, Yang Q, Burgess S, Haycock PC, Borges MC, Cho Y, Carnegie R, Howell A, Robinson J, Thomas LF, Brumpton BM, Hveem K, Hallan S, Franceschini N, Morris AP, Köttgen A, Pattaro C, Wuttke M, Yamamoto M, Kashihara N, Akiyama M, Kanai M, Matsuda K, Kamatani Y, Okada Y, Walters R, Millwood IY, Chen Z, Davey Smith G, Barbour S, Yu C, Åsvold BO, Zhang H, Gaunt TR. Int J Epidemiol.:The Prevalence of Locomotive Syndrome and its Associated Factors in Patients With Type 2 Diabetes Mellitus. 2022;6;50(6):1995-2010.
- Kitani T, Kidokoro K, Nakata T, Kirita Y, Nakamura I, Nakai K, Yagi-Tomita A, Ida T, Uehara-Watanabe N, Ikeda K, Yamashita N, Humphreys BD, Kashihara N, Matoba S, Tamagaki K, Kusaba T.:Kidney vascular congestion exacerbates acute kidney injury in mice. Kidney Int. 2022;101(3):551-562.
- Matsuzaki K, Aoki R, Nihei Y, Suzuki H, Kihara M, Yokoo T, Kashihara N, Narita I, Suzuki Y.:Correction to: Gross hematuria after SARS-CoV-2 vaccination: questionnaire survey in Japan. Clin Exp Nephrol. 2022 Apr;26(4):323-324. doi: 10.1007/s10157-021-02164-y. Erratum for: Clin Exp Nephrol. 2022;26(4):316-322.
- Ohya Y, Kario K, Itoh H, Nishiyama A, Ishimitsu T, Ichihara A, Kai H, Kashihara N, Katsuya T, Miura K, Mukoyama M, Nakamura S, Node K, Ohishi M, Saito S, Shibata H, Shimosawa T, Tamura K, Toyoda K, Ali MAM, Chia YC, Constantine G, Erwinanto E, Ihm SH, Kao HL, Van Minh H, Narasingan SN, Ona DID, Siddique S, Sukonthasarn A, Teo BW, Unurjargal T, Wang JG, Wang TD, Raukgi H.:Statement of the Asian Hypertension Society Network: the Okinawa Declaration on the unity of hypertension societies in Asian countries and regions to overcome hypertension and hypertension-related diseases. Hypertens Res. 2022 Jan;45(1):1-2. doi: 10.1038/s41440-021-00781-4. Epub 2021;9.
- Nagashima M, Kawakami M, Hayashi M, Kumagai R, Kasuya F, Yoshida I, Kashihara N, Morita K, Yamada K, Fujiwara T, Kitamura K, Yoshida H, Chiba T, Sadamasu K.:RNA Detection Using RT-qPCR and Non-Isolation of SARS-CoV-2 in Concentrated Wastewater (June-August 2020, Tokyo). Jpn J Infect Dis. 2022;24;75(2):212-215.
2021年
- Yamamoto T, Kadoya H, Urabe E, Itano S, Sasaki T, Kashihara N:A rare case of amyloid light-chain amyloidosis with bilateral perirenal hematoma shortly after initiation of peritoneal dialysis. CEN Case Rep. 2021 Jan 7.
- Tokuyama A, Kanda E, Itano S, Kondo M, Wada Y, Kadoya H, Kidokoro K, Nagasu H, Sasaki T, Kashihara N:Effect of zinc deficiency on chronic kidney disease progression and effect modification by hypoalbuminemia. PLoS One. 2021 May 11;16(5):e0251554.
- Ohsawa R, Kadoya H, Obata A, Obata T, Tokuyama A, Sasaki T, Kashihara N, Kaneto H:Renal cell carcinoma sharply captured by imaging technology at an early stage in a hemodialysis patient: Usefulness of noninvasive monochrome superb microvascular imaging. Hemodial Int. 2021 Mar 29.
- Nishimura K, Taguchi K, Kishi S, Brooks CR, Ochi A, Kadoya H, Ikeda Y, Miyoshi M, Tamaki M, Abe H, Aihara KI, Kashihara N, Nagai K:Dual disruption of eNOS and ApoE gene accelerates kidney fibrosis and senescence after injury. Biochem Biophys Res Commun. 2021 Jun 4;556:142-148.
- Desposito D, Schiessl IM, Gyarmati G, Riquier-Brison A, Izuhara A, Kadoya H, Der B, Shroff UN, Hong YK, Peti-Peterdi J:Serial intravital imaging captures dynamic and functional endothelial remodeling with single-cell resolution. JCI Insight. 2021 Apr 13;123392.
- Tokuyama A, Kadoya H, Obata A, Obata T, Sasaki T, Kashihara N:Roxadustat and thyroid-stimulating hormone suppression. Clin Kidney J. 2021 Jan 20;14(5):1472-1474.
- Maruyama Y, Araki M, Kidokoro K, Sogawa Y, Yoshinaga K, Mitsui Y, Sadahira T, Wada K, Watanabe M, Watanabe T, Kashihara N, Nasu Y:Evaluation of Neutrophil Dynamics Change by Protective Effect of Tadalafil After Renal Ischemia/Reperfusion Using In Vivo Real-time Imaging. Transplantation.Apr 27,2021.
- Nishiwaki H, Niihata K, Shimizu S, Shibagak Y, Yamamoto R , Nitta K, Tsukamoto T, Uchida S, Takeda A, Okada H, Narita I, Isaka Y, Kurita N : Japan Nephrotic Syndrome Cohort Study group:Incidence and factors associated with prescribing renin-angiotensin-system inhibitors in adult idiopathic nephrotic syndrome: A nationwide cohort study. J Clin Hypertens (Greenwich). 2021 May;23(5):999-1007.
2020年
- Kadoya H, Satoh M, Nishi Y, Kondo M, Wada Y, Sogawa Y, Kidokoro K, Nagasu H, Sasaki T, Kashihara N:Klotho is a novel therapeutic target in peritoneal fibrosis via Wnt signaling inhibition. Nephrol Dial Transplant. 2020 May 1;35(5):773-781.
- Nakagawa N, Sofue T, Kanda E, Nagasu H, Matsushita K, Nangaku M, Maruyama S, Wada T, Terada Y, Yamagata K, Narita I, Yanagita M, Sugiyama H, Shigematsu T, Ito T, Tamura K, Isaka Y, Okada H, Tsuruya K, Yokoyama H, Nakashima N, Kataoka H, Ohe K, Okada M, Kashihara N:J-CKD-DB: a nationwide multicentre electronic health record-based chronic kidney disease database in Japan. Sci Rep. 2020 Apr 30;10(1):7351.
- Sofue T, Nakagawa N, Kanda E, Nagasu H, Matsushita K, Nangaku M, Maruyama S, Wada T, Terada Y, Yamagata K, Narita I, Yanagita M, Sugiyama H, Shigematsu T, Ito T, Tamura K, Isaka Y, Okada H, Tsuruya K, Yokoyama H, Nakashima N, Kataoka H, Ohe K, Okada M, Kashihara N:Prevalences of hyperuricemia and electrolyte abnormalities in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB). PLoS One. 2020 Oct 15;15(10):e0240402.
- Sofue T, Nakagawa N, Kanda E, Nagasu H, Matsushita K, Nangaku M, Maruyama S, Wada T, Terada Y, Yamagata K, Narita I, Yanagita M, Sugiyama H, Shigematsu T, Ito T, Tamura K, Isaka Y, Okada H, Tsuruya K, Yokoyama H, Nakashima N, Kataoka H, Ohe K, Okada M, Kashihara N:Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB). PLoS One. 2020 Jul 20;15(7):e0236132.
- Itano S, Yano Y, Nagasu H, Tomiyama H, Kanegae H, Makino H, Higashi Y, Kobayashi Y, Sogawa Y, Satoh M, Suzuki K, Raymond R.T, Matthew B, George B, and Kashihara N:Association of Arterial Stiffness With Kidney Function Among Adults Without Chronic Kidney Disease. Am J Hypertens. 2020 Nov 3;33(11):1003-1010.
- Sogawa Y, Kadoya H, Kashihara N:Drastic change in protein intake may cause a rapid decline of residual renal function after initiation of peritoneal dialysis. Ther Apher Dial. 2020 Dec;24(6):736-738.
- Itano S, Kadoya H, Satoh M, Nakamura T, Murase T, Sasaki T, Kanwar YS, Kashihara N:Non-purine selective xanthine oxidase inhibitor ameliorates glomerular endothelial injury in InsAkita diabetic mice. Am J Physiol Renal Physiol. 2020 Nov 1;319(5):F765-F772.
- Tang SCW, Yu X, Chen HC, Kashihara N, Park HC, Liew A, Goh BL, Nazareth MGC, Bunnag S, Tan J, Lun V, Lydia A, Sharma SK, Hoque E, Togtokh A, Ghnaimet M, Jha V:Dialysis Care and Dialysis Funding in Asia. Am J Kidney Dis. 2020 May;75(5):772-781.
- Ito S, Kashihara N, Shikata K, Nangaku M, Wada T, Okuda Y, Sawanobori T:Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN): Phase 3 Randomized Controlled Clinical Trial. Clin J Am Soc Nephrol. 2020 Dec 7;15(12):1715-1727.
- Kashihara N, Yamasaki Y, Osonoi T, Harada H, Shibagaki Y, Zhao J, Kim H, Yajima T, Sarai N:A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia. Clin Exp Nephrol. 2021 Feb;25(2):140-149.
- Katsuno T, Ito Y, Kagami S, Kitamura H, Maruyama S, Shimizu A, Sugiyama H, Sato H, Yokoyama H, Kashihara N:A nationwide cross-sectional analysis of thrombotic microangiopathy in the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol. 2020 Sep;24(9):789-797.
- Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y:Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS). Clin Exp Nephrol. 2020 Jun;24(6):526-540.
- Kashihara N, Nishio T, Osonoi T, Saka Y, Imasawa T, Ohtake T, Mizuno H, Shibagaki Y, Kim H, Yajima T, Sarai N:Correction of serum potassium with sodium zirconium cyclosilicate in Japanese patients with hyperkalemia: a randomized, dose-response, phase 2/3 study. Clin Exp Nephrol. 2020 Dec;24(12):1144-1153.
- Yokoyama H, Yamamoto R, Imai E, Maruyama S, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Furuichi K, Fujimoto K, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y:Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS). Clin Exp Nephrol. 2020 Oct;24(10):893-909.
- Bandaru S, Sano S, Shimizu Y, Seki Y, Okano Y, Sasaki T, Wada H, Otsuki T, Ito T:Impact of heavy rains of 2018 in western Japan: disaster-induced health outcomes among the population of Innoshima Island. Heliyon. 2020 May 25;6(5):e03942.
- Kadoya H, Yu N, Schiessl IM, Riquier-Briston A, Gyarmati G, Desposito D, Kidokoro K, Butler MJ, Jacob CO, Peti-Peterdi J. :Essential role and therapeutic targeting of the glomerular endothelial glycocalyx in lupus nephritis. JCI Insight. 2020 Oct 2;5(19):e131252.
- Yamaguchi R, Kawazoe Y, Shimamoto K, Shinohara E, Tsukamoto T, Shintani-Domoto Y, Nagasu H, Uozaki H, Ushiku T, Nangaku M, Kashihara N, Shimizu A, Nagata M, Ohe K:Glomerular Classification Using Convolutional Neural Networks Based on Defined Annotation Criteria and Concordance Evaluation Among Clinicians. JCI Insight. 2020 Oct 2;5(19):e131252.
- Kanda E, Kashihara N, Kohsaka S, Okami S, Yajima T:Clinical and Economic Burden of Hyperkalemia: A Nationwide Hospital-Based Cohort Study in Japan. Kidney Med. 2020 Oct 17;2(6):742-752.e1.
- Wheeler DC, Stefansson BV, Batiushin M, Bilchenko O, Cherney DZI, Chertow GM, Douthat W, Dwyer JP, Escudero E, Pecoits-Filho R, Furuland H, Górriz JL, Greene T, Haller H, Hou FF, Kang SW, Isidto R, Khullar D, Mark PB, McMurray JJV, Kashihara N, Nowicki M, Persson F, Correa-Rotter R, Rossing P, Toto RD, Umanath K, Van Bui P, Wittmann I, Lindberg M, Sjöström CD, Langkilde AM, Heerspink HJL:The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics. Nephrol Dial Transplant. 2020 Oct 1;35(10):1700-1711.
- Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann JFE, McMurray JJV, Lindberg M, Rossing P, Sjöström CD, Toto RD, Langkilde AM, Wheeler DC; DAPA-CKD Trial Committees and Investigators:Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020 Oct 8;383(15):1436-1446.
- Kanda E, Epureanu BI, Adachi T, Tsuruta Y, Kikuchi K, Kashihara N, Abe M, Masakane I, Nitta K:Application of explainable ensemble artificial intelligence model to categorization of hemodialysis-patient and treatment using nationwide-real-world data in Japan. PLoS One. 2020 May 29;15(5):e0233491.
- Kashihara N, Kidokoro K, Kanda E:Renoprotective effects of sodium-glucose cotransporter-2 inhibitors and underlying mechanisms. Curr Opin Nephrol Hypertens. 2020 Jan;29(1):112-118.
- Tang SCW, Yu X, Chen HC, Kashihara N, Park HC, Liew A, Goh BL, Nazareth MGC, Bunnag S, Tan J, Lun V, Lydia A, Sharma SK, Hoque E, Togtokh A, Ghnaimet M, Jha V:Dialysis Care and Dialysis Funding in Asia. Am J Kidney Dis. 2020 May;75(5):772-781.
受賞
2022年
Japan Kidney Council 2022 奨励賞 高須 将伸
川崎医学会賞 川崎医学会誌論文賞 近藤 恵
日本腎臓学会 感謝状 柏原 直樹
2021年
第29回中国腎不全研究協会学術集会 優秀演題賞 高須 将伸
川崎医科大学附属病院 病院長より 感謝状 長洲 一
川崎医科大学附属病院 病院長より 感謝状 城所 研吾
日本透析医学会奨励賞 角谷 裕之
2020年
The 9th chronic kidney disease CKD Frontier Award 徳山 敦之
公益財団法人ウエスコ学術振興財団 2020年度学術研究費助成金 角谷 裕之
公益財団法人川崎医学・医療福祉学振興会 教育研究助成金 和田 佳久
第63回日本腎臓学会学術総会 優秀演題賞 角谷 裕之
川崎医科大学附属病院卒後臨床研修 ベスト指導医 山内 祐
Okayama Prefectural Medical Association Academic Award 2020 角谷 裕之